Related references
Note: Only part of the references are listed.Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])
Harry H. Yoon et al.
EUROPEAN JOURNAL OF CANCER (2021)
Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)
Maarten C. C. M. Hulshof et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Induction chemotherapy followed by definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: a randomized phase II trial
Shiliang Liu et al.
NATURE COMMUNICATIONS (2021)
Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Hyeon Kang Koh et al.
ANTICANCER RESEARCH (2020)
Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
An-Du Zhang et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
Hideaki Bando et al.
BMC CANCER (2020)
Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment
Shao-Lun Lu et al.
EJSO (2019)
Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial
Yun Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Positron-Emission Tomography Scan-Directed Chemoradiation for Esophageal Squamous Cell Carcinoma: No Benefit for a Change in Chemotherapy in Positron-Emission Tomography Nonresponders
Megan Greally et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
With or without consolidation chemotherapy using cisplatin/5-FU after concurrent chemoradiotherapy in stage II-III squamous cell carcinoma of the esophagus: A propensity score-matched analysis
Yongshun Chen et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Consolidation systemic treatment after radiochemotherapy for unresectable stage III non-small cell lung cancer
Marcin Skrzypski et al.
CANCER TREATMENT REVIEWS (2018)
Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma
Hongmin Chen et al.
MEDICAL SCIENCE MONITOR (2018)
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Mingqiu Chen et al.
RADIATION ONCOLOGY (2018)
Recursive Partitioning Analysis Identifies Pretreatment Risk Groups for the Utility of Induction Chemotherapy Before Definitive Chemoradiation Therapy in Esophageal Cancer
Mian Xi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Neoadjuvant chemotherapy may not benefit esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy
Ming-Qiu Chen et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2017)
Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma
Li-Ling Luo et al.
JOURNAL OF CANCER (2017)
Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer
Sheng-Xi Wu et al.
SCIENTIFIC REPORTS (2017)
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04
Jin Seok Ahn et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2014)
Is Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy Beneficial for Patients with Locally Advanced Non-Small-Cell Lung Cancer?: A Pooled Analysis of the Literature
Kazuyuki Tsujino et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Clinical Prognostic Factors for Locally Advanced Esophageal Squamous Carcinoma Treated after Definitive Chemoradiotherapy
Dae-Eun Kim et al.
CANCER RESEARCH AND TREATMENT (2013)
Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
Edwin P. Hui et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Radiation therapy for recurrent esophageal cancer after surgery: Clinical results and prognostic factors
Yoshiyuki Shioyama et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Share Paper
